Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousGraft vs Host DiseaseBone MarrowTransplantation ConditioningBone Marrow CellsTransplantation, AutologousBusulfanHematologic NeoplasmsTissue DonorsWhole-Body IrradiationImmunosuppressive AgentsLiver TransplantationGraft SurvivalKidney TransplantationAnemia, AplasticLeukemiaTransplantation ChimeraHematopoietic Stem CellsTreatment OutcomeCytomegalovirus InfectionsHistocompatibility TestingHistocompatibilityRetrospective StudiesBone Marrow PurgingBone and BonesHematopoiesisGraft RejectionStem Cell TransplantationTransplantation, IsogeneicCyclophosphamideRecurrenceHeart TransplantationCombined Modality TherapyTime FactorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow DiseasesTransplantation ImmunologyLeukemia, Myeloid, AcuteMice, Inbred C57BLLung TransplantationRadiation ChimeraAntiviral AgentsImmunosuppressionHepatic Veno-Occlusive DiseaseRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantationLeukemia, MyeloidAcute DiseaseBone Marrow ExaminationSurvival AnalysisLymphocyte DepletionCyclosporineHLA AntigensLeukocyte TransfusionLymphoma, Non-HodgkinGraft vs Host ReactionColony-Forming Units AssayOrgan TransplantationT-LymphocytesMyelodysplastic SyndromesHematologic DiseasesBone Marrow NeoplasmsChimeraSevere Combined ImmunodeficiencySurvival RateFollow-Up StudiesCell DifferentiationLymphocyte TransfusionAntigens, CD34Cell TransplantationPeripheral Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationActuarial AnalysisGraft vs Leukemia EffectGraft vs Tumor EffectDisease-Free SurvivalMultiple MyelomaGranulocyte Colony-Stimulating FactorFlow CytometryLiving DonorsCarmustineImmunocompromised HostNuclear FamilyMelphalanIslets of Langerhans TransplantationOpportunistic InfectionsCytarabineAntilymphocyte SerumCells, CulturedPostoperative ComplicationsLymphomaFatal OutcomeSpleenPancytopeniaLeukocyte CountTransplants